Baker Felix insider trades
Baker Felix has filed 24 Form 4s with the SEC that we hold, for Incyte Corp (INCY) (Director, 10% owner), Kodiak Sciences Inc. (KOD) (Director, 10% owner), Madrigal Pharmaceuticals, INC. (MDGL) (Director) and IGMS (Director), among 12 companies in all. Across all of them we count 100 purchases worth $282.4M and 0 sales worth $0 reported on Form 4. In the last 12 months: 6 purchases ($172.8M) and 0 sales ($0). The largest single trade was a purchase of 1,838,621 shares of Kymera Therapeutics, Inc. worth $158.1M, dated 2025-12-11. The first filing on our record is dated 2021-07-02 and the latest 2026-01-06.
Incyte Corp (INCY)
Director, 10% owner · 7 filings · 8 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-02-17 | P, purchase reported on Form 4 | 285,672 | $19.4M | 2022-02-22 |
| 2022-02-17 | P, purchase reported on Form 4 | 7,300 | $492.0K | 2022-02-22 |
| 2022-02-18 | P, purchase reported on Form 4 | 22,178 | $1.5M | 2022-02-22 |
| 2022-02-18 | P, purchase reported on Form 4 | 1,827 | $125.0K | 2022-02-22 |
| 2022-02-18 | P, purchase reported on Form 4 | 8,296 | $567.2K | 2022-02-22 |
| 2022-02-18 | P, purchase reported on Form 4 | 100,731 | $6.9M | 2022-02-22 |
| 2022-02-22 | P, purchase reported on Form 4 | 7,566 | $515.0K | 2022-02-22 |
| 2022-02-22 | P, purchase reported on Form 4 | 92,234 | $6.3M | 2022-02-22 |
Kodiak Sciences Inc. (KOD)
Director, 10% owner · 4 filings · 26 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-01-21 | P, purchase reported on Form 4 | 102,207 | $5.8M | 2022-01-25 |
| 2022-01-21 | P, purchase reported on Form 4 | 31,207 | $1.8M | 2022-01-25 |
| 2022-01-24 | P, purchase reported on Form 4 | 57,547 | $3.4M | 2022-01-25 |
| 2022-01-24 | P, purchase reported on Form 4 | 19,750 | $1.1M | 2022-01-25 |
| 2022-01-24 | P, purchase reported on Form 4 | 1,200 | $67.9K | 2022-01-25 |
| 2022-01-24 | P, purchase reported on Form 4 | 116,083 | $6.6M | 2022-01-25 |
| 2022-01-24 | P, purchase reported on Form 4 | 25,900 | $1.5M | 2022-01-25 |
| 2022-01-24 | P, purchase reported on Form 4 | 132,367 | $7.7M | 2022-01-25 |
| 2022-01-24 | P, purchase reported on Form 4 | 9,350 | $549.4K | 2022-01-25 |
| 2022-01-25 | P, purchase reported on Form 4 | 5,500 | $323.9K | 2022-01-25 |
| 2022-05-25 | P, purchase reported on Form 4 | 42,250 | $278.9K | 2022-05-27 |
| 2022-05-25 | P, purchase reported on Form 4 | 4,984 | $32.9K | 2022-05-27 |
| 2022-05-25 | P, purchase reported on Form 4 | 48,222 | $314.9K | 2022-05-27 |
| 2022-05-25 | P, purchase reported on Form 4 | 5,688 | $37.1K | 2022-05-27 |
| 2022-05-26 | P, purchase reported on Form 4 | 3,432 | $23.0K | 2022-05-27 |
| 2022-05-26 | P, purchase reported on Form 4 | 29,090 | $195.2K | 2022-05-27 |
| 2022-05-26 | P, purchase reported on Form 4 | 6,299 | $42.5K | 2022-05-27 |
| 2022-05-26 | P, purchase reported on Form 4 | 53,401 | $360.5K | 2022-05-27 |
| 2022-05-26 | P, purchase reported on Form 4 | 116 | $784 | 2022-05-27 |
| 2022-05-26 | P, purchase reported on Form 4 | 984 | $6.7K | 2022-05-27 |
| 2022-05-27 | P, purchase reported on Form 4 | 42 | $279 | 2022-05-27 |
| 2022-05-27 | P, purchase reported on Form 4 | 358 | $2.4K | 2022-05-27 |
| 2022-05-27 | P, purchase reported on Form 4 | 6,026 | $40.9K | 2022-05-27 |
| 2022-05-27 | P, purchase reported on Form 4 | 51,082 | $346.3K | 2022-05-27 |
| 2022-05-27 | P, purchase reported on Form 4 | 10,386 | $71.9K | 2022-05-27 |
| 2022-05-27 | P, purchase reported on Form 4 | 88,046 | $609.3K | 2022-05-27 |
Madrigal Pharmaceuticals, INC. (MDGL)
Director · 3 filings · 58 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-11-13 | P, purchase reported on Form 4 | 265 | $36.1K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 3,144 | $428.1K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 311 | $42.6K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 3,693 | $505.6K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 390 | $53.7K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 4,631 | $637.6K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 427 | $60.2K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 5,072 | $714.6K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 910 | $128.7K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 10,790 | $1.5M | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 109 | $15.6K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 1,291 | $184.4K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 537 | $78.1K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 6,369 | $926.4K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 252 | $36.8K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 2,994 | $437.1K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 2,228 | $325.8K | 2023-11-15 |
| 2023-11-13 | P, purchase reported on Form 4 | 26,426 | $3.9M | 2023-11-15 |
| 2023-11-14 | P, purchase reported on Form 4 | 54 | $8.2K | 2023-11-15 |
| 2023-11-14 | P, purchase reported on Form 4 | 646 | $98.3K | 2023-11-15 |
| 2023-11-14 | P, purchase reported on Form 4 | 242 | $37.1K | 2023-11-15 |
| 2023-11-14 | P, purchase reported on Form 4 | 2,877 | $440.9K | 2023-11-15 |
| 2023-11-14 | P, purchase reported on Form 4 | 683 | $105.2K | 2023-11-15 |
| 2023-11-14 | P, purchase reported on Form 4 | 8,098 | $1.2M | 2023-11-15 |
| 2023-11-14 | P, purchase reported on Form 4 | 1,142 | $176.8K | 2023-11-15 |
| 2023-11-14 | P, purchase reported on Form 4 | 13,548 | $2.1M | 2023-11-15 |
| 2023-11-14 | P, purchase reported on Form 4 | 299 | $46.2K | 2023-11-15 |
| 2023-11-14 | P, purchase reported on Form 4 | 3,542 | $547.6K | 2023-11-15 |
| 2023-11-14 | P, purchase reported on Form 4 | 507 | $77.3K | 2023-11-15 |
| 2023-11-14 | P, purchase reported on Form 4 | 6,022 | $918.2K | 2023-11-15 |
| 2025-08-18 | P, purchase reported on Form 4 | 506 | $187.7K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 5,494 | $2.0M | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 253 | $93.4K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 1,419 | $523.4K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 131 | $48.3K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 4,798 | $1.8M | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 442 | $162.6K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 2,289 | $838.5K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 211 | $77.3K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 2,772 | $1.0M | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 255 | $92.8K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 5,587 | $2.0M | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 515 | $186.6K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 5,443 | $2.0M | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 502 | $181.4K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 8,514 | $3.1M | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 784 | $281.8K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 2,472 | $885.5K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 228 | $81.7K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 8,328 | $3.0M | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 767 | $273.8K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 916 | $325.2K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 84 | $29.8K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 1,923 | $680.5K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 177 | $62.6K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 10,128 | $3.8M | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 933 | $347.2K | 2025-08-20 |
| 2025-08-18 | P, purchase reported on Form 4 | 2,747 | $1.0M | 2025-08-20 |
IGMS
Director · 2 filings · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Acadia Pharmaceuticals INC (ACAD)
Director, 10% owner · 1 filing · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Bicycle Therapeutics PLC (BCYC)
Director, 10% owner · 1 filing · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Entrada Therapeutics, Inc. (TRDA)
10% owner · 1 filing · 4 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-11-20 | P, purchase reported on Form 4 | 13,082 | $118.7K | 2025-11-24 |
| 2025-11-20 | P, purchase reported on Form 4 | 1,186 | $10.8K | 2025-11-24 |
| 2025-11-20 | P, purchase reported on Form 4 | 13,386 | $121.4K | 2025-11-24 |
| 2025-11-20 | P, purchase reported on Form 4 | 1,213 | $11.0K | 2025-11-24 |
KALA BIO, Inc. (KALA)
10% owner · 1 filing · 2 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-12-30 | P, purchase reported on Form 4 | 279,939 | $1.8M | 2024-12-31 |
| 2024-12-30 | P, purchase reported on Form 4 | 30,620 | $197.2K | 2024-12-31 |
Kymera Therapeutics, Inc. (KYMR)
Director, 10% owner · 1 filing · 2 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-12-11 | P, purchase reported on Form 4 | 167,192 | $14.4M | 2025-12-11 |
| 2025-12-11 | P, purchase reported on Form 4 | 1,838,621 | $158.1M | 2025-12-11 |
Neurogene Inc. (NLTX)
Director · 1 filing · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
SGEN
Director, 10% owner · 1 filing · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
vTv Therapeutics Inc. (VTVT)
Director · 1 filing · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1087940) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms